(Q36062119)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15748206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

review article

1 reference

title

Lipid based particulate formulations for the delivery of antigen (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15748206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15748206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Melissa J Copland

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15748206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Nigel M Davies

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15748206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Margaret A Baird

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15748206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 April 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15748206%20AND%20SRC:MED&resulttype=core&format=json

Immunology & Cell Biology

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15748206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15748206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15748206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

97-105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15748206%20AND%20SRC:MED&resulttype=core&format=json

Dendritic cells and the control of immunity

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Mechanisms of vaccine adjuvant activity: initiation and regulation of immune responses by vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Adjuvants--a balance between toxicity and adjuvanticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

On cross-priming of MHC class I-specific CTL: rule or exception?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Recent advances in vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Nanostructured lipid matrices for improved microencapsulation of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Production of solid lipid nanoparticles (SLN): scaling up feasibilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Solid lipid nanoparticles: production, characterization and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Immunological adjuvants: a role for liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Toxicity screening of liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Liposomal delivery of antigen to human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Current status of pH-sensitive liposomes in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Delivery of protein antigen to the major histocompatibility complex class I-restricted antigen presentation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

pH sensitive liposomes provide an efficient means of sensitizing target cells to class I restricted CTL recognition of a soluble protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Stability of liposomes on long term storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Liposomes and ISCOMS as vaccine formulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Immunogenicity of immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells. mangala.rao@na.amedd.army.mil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Immunogenicity and protectivity of a new liposomal hepatitis A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Virosomal adjuvanted antigen delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Design and selection of vaccine adjuvants: animal models and human trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Advances in vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Adjuvants designed for veterinary and human vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Adjuvants for human vaccines--current status, problems and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Studies on experimental adjuvanted influenza vaccines: comparison of immune stimulating complexes (Iscoms) and oil-in-water vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Immune responses to ISCOM formulations in animal and primate models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Internalization of iscom-borne antigens and presentation under MHC class I or class II restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Priming in vivo and quantification in vitro of class I MHC-restricted cytotoxic T cells to human papilloma virus type 11 early proteins (E6 and E7) using immunostimulating complexes (ISCOMs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM? vaccines and conventional vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

Soluble proteins incorporate into ISCOMs after covalent attachment of fatty acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

ISCOMs and other saponin based adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01315.X

10.1111/J.1440-1711.2005.01315.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15748206%20AND%20SRC:MED&resulttype=core&format=json

release_cbu5qgqs2zbltb2qgiuudmdwkm

9 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cbu5qgqs2zbltb2qgiuudmdwkm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference